prompt stringclasses 1
value | id stringlengths 11 11 | instruction stringlengths 710 15.1k | output stringlengths 47 105 | Train int64 0 0 |
|---|---|---|---|---|
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03874884 | {'Official Title': '177Lu-PSMA-617 Therapy and Olaparib in Patients With Metastatic Castration Resistant Prostate Cancer', 'Brief Summary': 'This phase 1 dose-escalation and dose-expansion study is designed to evaluate the safety and tolerability of olaparib in combination with 177Lutetium-Prostate Specific Membrane An... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03635567 | {'Official Title': 'A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826)', 'Brief Summary': 'The purpose of this study is to assess the... | {'Arm - Disease - Stage of Cancer': 'Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03635567 | {'Official Title': 'A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Pembrolizumab (MK-3475) Plus Chemotherapy Versus Chemotherapy Plus Placebo for the First-Line Treatment of Persistent, Recurrent, or Metastatic Cervical Cancer (KEYNOTE-826)', 'Brief Summary': 'The purpose of this study is to assess the... | {'Arm - Disease - Stage of Cancer': 'Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03907488 | {'Official Title': 'A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma', 'Brief Summary': "This phase III trial compares immunotherapy drugs (nivolumab or brentuximab ved... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Stage III, Stage IV, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03907488 | {'Official Title': 'A Phase III, Randomized Study of Nivolumab (Opdivo) Plus AVD or Brentuximab Vedotin (Adcetris) Plus AVD in Patients (Age >/= 12 Years) With Newly Diagnosed Advanced Stage Classical Hodgkin Lymphoma', 'Brief Summary': "This phase III trial compares immunotherapy drugs (nivolumab or brentuximab ved... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Stage III, Stage IV, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03936270 | {'Official Title': 'Palbociclib Plus Letrozole Treatment After Progression to Second Line Chemotherapy for Women With ER/PR-positive Ovarian Cancer.', 'Brief Summary': 'The primary objective of this study is to evaluate 12 weeks progression-free survival (PFS) rate of Palbociclib plus Letrozole in ER/PR positive endome... | {'Arm - Disease - Stage of Cancer': 'High-Grade, Metastatic, Locoregional, Locally Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03627728 | {'Official Title': 'Phase II Randomized Study of Maintenance Regorafenib vs Placebo in no Progression Patients After First-line Platinum and Fluoropyrimidines Based Chemotherapy in HER2 Negative Locally Advanced/Metastatic Gastric or Gastroesophagel Junction Cancer (a-MANTRA Study)', 'Brief Summary': 'Randomized, doubl... | {'Arm - Disease - Stage of Cancer': 'Locally advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03627728 | {'Official Title': 'Phase II Randomized Study of Maintenance Regorafenib vs Placebo in no Progression Patients After First-line Platinum and Fluoropyrimidines Based Chemotherapy in HER2 Negative Locally Advanced/Metastatic Gastric or Gastroesophagel Junction Cancer (a-MANTRA Study)', 'Brief Summary': 'Randomized, doubl... | {'Arm - Disease - Stage of Cancer': 'Locally advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04590599 | {'Official Title': 'A Randomized, Double-blind, Controlled, Parallel-cohort Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy', 'Brief Summary': ... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04590599 | {'Official Title': 'A Randomized, Double-blind, Controlled, Parallel-cohort Phase II Clinical Study to Assess the Efficacy and Safety of IBI310 or Placebo Combined With Sintilimab for Advanced Cervical Cancer Subjects Who Have Failed or Cannot Tolerate First-line or Above Platinum-based Chemotherapy', 'Brief Summary': ... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05608785 | {'Official Title': 'Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes', 'Brief Summary': 'Abstract Study title: Single-center, Multi-cohort Explorato... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05608785 | {'Official Title': 'Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes', 'Brief Summary': 'Abstract Study title: Single-center, Multi-cohort Explorato... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05608785 | {'Official Title': 'Single-center, Multi-cohort Exploratory Phase Ib/II Clinical Study of First-line Treatment of Unresectable Locally Advanced/Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction Based on Different Genotypes', 'Brief Summary': 'Abstract Study title: Single-center, Multi-cohort Explorato... | {'Arm - Disease - Stage of Cancer': 'Locally Advanced, Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05715840 | {'Official Title': 'A Randomised, Double-blind, Placebo-controlled, Multicentre Phase Ш Clinical Study to Evaluate the Efficacy and Safety of First-line Treatment With SG001 Plus Chemotherapy±Bevacizumab Versus Placebo Plus Chemotherapy±Bevacizumab for PD-L1 Positive (CPS≥1) Women With Recurrent, or Metastatic Cervical... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05715840 | {'Official Title': 'A Randomised, Double-blind, Placebo-controlled, Multicentre Phase Ш Clinical Study to Evaluate the Efficacy and Safety of First-line Treatment With SG001 Plus Chemotherapy±Bevacizumab Versus Placebo Plus Chemotherapy±Bevacizumab for PD-L1 Positive (CPS≥1) Women With Recurrent, or Metastatic Cervical... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05529667 | {'Official Title': 'An Open Label, Single-Arm, Multi-center Phase Ib/II Study to Evaluate the Safety and Efficacy of INCB054828 in Combination With Paclitaxel as a Second Line Treatment in Recurrent/Advanced Gastric Cancer With FGFs/FGFRs Genetic Aberration.', 'Brief Summary': 'This study was conducted as a second-line... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)', 'Brief... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Advanced, Stage III, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)', 'Brief... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Advanced, Stage III, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04269200 | {'Official Title': 'A Randomised, Multicentre, Double-blind, Placebo-controlled, Phase III Study of First-line Carboplatin and Paclitaxel in Combination With Durvalumab, Followed by Maintenance Durvalumab With or Without Olaparib in Patients With Newly Diagnosed Advanced or Recurrent Endometrial Cancer (DUO-E)', 'Brief... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed, Advanced, Stage III, Stage IV'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03617679 | {'Official Title': 'A Phase II, Randomized, Double-Blind Study of the Use of Rucaparib vs. Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer', 'Brief Summary': 'This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer, a... | {'Arm - Disease - Stage of Cancer': 'Stage III, Stage IV, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03617679 | {'Official Title': 'A Phase II, Randomized, Double-Blind Study of the Use of Rucaparib vs. Placebo Maintenance Therapy in Metastatic and Recurrent Endometrial Cancer', 'Brief Summary': 'This study seeks to determine the effectiveness of Rucaparib as maintenance therapy for metastatic and recurrent endometrial cancer, a... | {'Arm - Disease - Stage of Cancer': 'Stage III, Stage IV, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05422911 | {'Official Title': 'A Phase 2 Randomized Study of YONSA® (Abiraterone Acetate), Enzalutamide or Apalutamide as First Line Therapy in Veterans With Castrate-sensitive Prostate Cancer', 'Brief Summary': 'The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Ve... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05422911 | {'Official Title': 'A Phase 2 Randomized Study of YONSA® (Abiraterone Acetate), Enzalutamide or Apalutamide as First Line Therapy in Veterans With Castrate-sensitive Prostate Cancer', 'Brief Summary': 'The investigators have used national VHA data to demonstrate real-world efficacy of abiraterone and enzalutamide in Ve... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04934722 | {'Official Title': 'A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)', 'Brief Summary': 'This study will assess the efficacy and safety of pemb... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04934722 | {'Official Title': 'A Phase 3, Randomized, Double-blind Trial of Pembrolizumab (MK-3475) Plus Enzalutamide Plus ADT Versus Placebo Plus Enzalutamide Plus ADT in Participants With Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) (KEYNOTE-991)', 'Brief Summary': 'This study will assess the efficacy and safety of pemb... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05201352 | {'Official Title': 'Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine', 'Brief Summary': 'Unre... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05201352 | {'Official Title': 'Multicentric Randomized Phase I/II Study to Evaluate Efficacy of Trifluridine/Tipiracil Plus XB2001 (Anti-IL-1α True Human Antibody) Versus Trifluridine/Tipiracil Plus Placebo in Metastatic Colorectal Cancer Patients After Failure of Oxaliplatin, Irinotecan, Fluoropyrimidine', 'Brief Summary': 'Unre... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03875235 | {'Official Title': 'A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination With Gemcitabine Plus Cisplatin Versus Placebo in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers', 'Brief Summary': 'Durv... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT03875235 | {'Official Title': 'A Phase III Randomized, Double-Blind Placebo Controlled, Multi-Regional, International Study of Durvalumab in Combination With Gemcitabine Plus Cisplatin Versus Placebo in Combination With Gemcitabine Plus Cisplatin for Patients With First-Line Advanced Biliary Tract Cancers', 'Brief Summary': 'Durv... | {'Arm - Disease - Stage of Cancer': 'Advanced, Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01972217 | {'Official Title': 'A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Study to Compare the Efficacy, Safety and Tolerability of Olaparib Versus Placebo When Given in Addition to Abiraterone Treatment in Patients With Metastatic Castrate-Resistant Prostate Cancer Who Have Received Prior Chemotherapy C... | {'Arm - Disease - Stage of Cancer': 'Metastatic '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01972217 | {'Official Title': 'A Randomised, Double-Blind, Placebo-Controlled, Multicentre Phase II Study to Compare the Efficacy, Safety and Tolerability of Olaparib Versus Placebo When Given in Addition to Abiraterone Treatment in Patients With Metastatic Castrate-Resistant Prostate Cancer Who Have Received Prior Chemotherapy C... | {'Arm - Disease - Stage of Cancer': 'Metastatic '} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT05797831 | {'Official Title': 'A Phase 2/3 Study of Navtemadlin as Maintenance Therapy in Subjects With TP53WT Advanced or Recurrent Endometrial Cancer Who Responded to Chemotherapy', 'Brief Summary': 'This study evaluates navtemadlin as maintenance treatment for patients with advanced or recurrent endometrial cancer (EC) who hav... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04634877 | {'Official Title': 'A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)', 'Brief Summary... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed,'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT04634877 | {'Official Title': 'A Phase 3, Randomized, Double-Blind Study of Pembrolizumab Versus Placebo in Combination With Adjuvant Chemotherapy With or Without Radiotherapy for the Treatment of Newly Diagnosed High-Risk Endometrial Cancer After Surgery With Curative Intent (KEYNOTE-B21 / ENGOT-en11 / GOG-3053)', 'Brief Summary... | {'Arm - Disease - Stage of Cancer': 'Newly Diagnosed'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02043678 | {'Official Title': 'A Phase III Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone/Prednisolone in the Treatment of Asymptomatic or Mildly Symptomatic Chemotherapy-naïve Subjects With Bone Predominant Metastatic Castration-resistant Prostat... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT02043678 | {'Official Title': 'A Phase III Randomized, Double-blind, Placebo-controlled Trial of Radium-223 Dichloride in Combination With Abiraterone Acetate and Prednisone/Prednisolone in the Treatment of Asymptomatic or Mildly Symptomatic Chemotherapy-naïve Subjects With Bone Predominant Metastatic Castration-resistant Prostat... | {'Arm - Disease - Stage of Cancer': 'Metastatic'} | 0 |
Stage of Cancer Extraction Guideline
1. Review the “arms data” and identify the stage of cancer from the clinical trial arm.
2. Rely only on "arms data" to identify the stage of cancer. The "arms data" may be incomplete or irrelevant. You should not make assumptions about the "arms data" beyond what is mentioned.
3. Ma... | NCT01068249 | {'Official Title': 'A Phase II Study of Letrozole and RAD001 (Everolimus) in Patients With Advanced or Recurrent Endometrial Cancer', 'Brief Summary': 'The goal of this clinical research study is to learn if the combination of RAD001 (everolimus) and Femara (letrozole) can help to control recurrent or progressive endom... | {'Arm - Disease - Stage of Cancer': 'Advanced'} | 0 |
End of preview. Expand in Data Studio
No dataset card yet
- Downloads last month
- 4